M T Murphy1, N Wang2, D T Felson3, M C Nevitt4, C E Lewis5, L Frey-Law6, A Guermazi7, N A Segal8. 1. Department of Rehabilitation Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mailstop 1046, Kansas City, KS, 66160, USA. Electronic address: mmurphy11@kumc.edu. 2. Department of Biostatistics and Epidemiology, Boston University, Boston, MA, USA. Electronic address: nwang10@bu.edu. 3. Department of Epidemiology, Boston University, Boston, MA, USA. Electronic address: dfelson@bu.edu. 4. Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA, USA. Electronic address: michael.nevitt@ucsf.edu. 5. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: celewis@uabmc.edu. 6. Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, USA. Electronic address: laura-freylaw@uiowa.edu. 7. Department of Radiology, Boston University, Boston, MA, USA. Electronic address: guermazi@bu.edu. 8. Department of Rehabilitation Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mailstop 1046, Kansas City, KS, 66160, USA. Electronic address: nsegal@kumc.edu.
Abstract
OBJECTIVE: This study aimed to determine longitudinal associations, including sex-specific differences, between greater knee flexor antagonist coactivation and worsening cartilage morphology in knees with or at risk for osteoarthritis (OA). DESIGN: Baseline measurements were collected at the 60-month visit of a longitudinal osteoarthritis study following community-dwelling participants (MOST). Knee flexor and extensor muscle activity were measured with surface electromyography during a maximal isokinetic knee extension task. MRI analyzed knee cartilage morphology at baseline and 24-month follow-up. Multivariable adjusted logistic regression models were used to assess associations between coactivation level and cartilage morphology worsening. RESULTS: Analysis of 373 women (mean ± SD age 67.4 ± 7.3 years and BMI 29.7 ± 5.0 kg/m2) and 240 men (66.5 ± 7.8 years and 29.9 ± 4.5 kg/m2) revealed that women had greater medial (P < 0.001), lateral (P < 0.001), and combined (P < 0.001) hamstring coactivation than men. In both sexes, combined hamstring coactivation was associated with patellofemoral cartilage morphology worsening [1.23 (1.02, 1.49)] and to a less significant degree with whole knee cartilage morphology worsening [1.21 (0.98, 1.49)]. In men, greater combined hamstring coactivation was associated with increased risk for whole knee [1.59 (1.06, 2.39)] and patellofemoral [1.38 (1.01, 1.88)] cartilage morphology worsening and point estimates suggested association between medial hamstring coactivation and medial tibiofemoral cartilage morphology worsening. No significant associations were detected between greater hamstring coactivation and cartilage morphology worsening in women. CONCLUSIONS: These findings suggest a longitudinal relationship between antagonist hamstring coactivation during isokinetic knee extensor testing and worsening of cartilage morphology over 24 months in men with or at risk for knee OA.
OBJECTIVE: This study aimed to determine longitudinal associations, including sex-specific differences, between greater knee flexor antagonist coactivation and worsening cartilage morphology in knees with or at risk for osteoarthritis (OA). DESIGN: Baseline measurements were collected at the 60-month visit of a longitudinal osteoarthritis study following community-dwelling participants (MOST). Knee flexor and extensor muscle activity were measured with surface electromyography during a maximal isokinetic knee extension task. MRI analyzed knee cartilage morphology at baseline and 24-month follow-up. Multivariable adjusted logistic regression models were used to assess associations between coactivation level and cartilage morphology worsening. RESULTS: Analysis of 373 women (mean ± SD age 67.4 ± 7.3 years and BMI 29.7 ± 5.0 kg/m2) and 240 men (66.5 ± 7.8 years and 29.9 ± 4.5 kg/m2) revealed that women had greater medial (P < 0.001), lateral (P < 0.001), and combined (P < 0.001) hamstring coactivation than men. In both sexes, combined hamstring coactivation was associated with patellofemoral cartilage morphology worsening [1.23 (1.02, 1.49)] and to a less significant degree with whole knee cartilage morphology worsening [1.21 (0.98, 1.49)]. In men, greater combined hamstring coactivation was associated with increased risk for whole knee [1.59 (1.06, 2.39)] and patellofemoral [1.38 (1.01, 1.88)] cartilage morphology worsening and point estimates suggested association between medial hamstring coactivation and medial tibiofemoral cartilage morphology worsening. No significant associations were detected between greater hamstring coactivation and cartilage morphology worsening in women. CONCLUSIONS: These findings suggest a longitudinal relationship between antagonist hamstring coactivation during isokinetic knee extensor testing and worsening of cartilage morphology over 24 months in men with or at risk for knee OA.
Authors: Jonathan A Gustafson; Megan E Robinson; G Kelley Fitzgerald; Scott Tashman; Shawn Farrokhi Journal: Clin Biomech (Bristol, Avon) Date: 2015-03-10 Impact factor: 2.063
Authors: J J Stefanik; L Frey-Law; N A Segal; J Niu; C E Lewis; M C Nevitt; T Neogi Journal: Osteoarthritis Cartilage Date: 2020-06-23 Impact factor: 6.576
Authors: C G Peterfy; A Guermazi; S Zaim; P F J Tirman; Y Miaux; D White; M Kothari; Y Lu; K Fye; S Zhao; H K Genant Journal: Osteoarthritis Cartilage Date: 2004-03 Impact factor: 6.576
Authors: Paul W Hodges; Wolbert van den Hoorn; Tim V Wrigley; Rana S Hinman; Kelly-Ann Bowles; Flavia Cicuttini; Yuanyuan Wang; Kim Bennell Journal: Man Ther Date: 2015-07-17
Authors: Elysia M Davis; Cheryl L Hubley-Kozey; Scott C Landry; Dianne M Ikeda; William D Stanish; Janie L Astephen Wilson Journal: Clin Biomech (Bristol, Avon) Date: 2018-12-20 Impact factor: 2.063
Authors: Philippe C Dixon; Sharleen Gomes; Richard A Preuss; Shawn M Robbins Journal: Clin Biomech (Bristol, Avon) Date: 2018-10-23 Impact factor: 2.063
Authors: Adam Trepczynski; Ines Kutzner; Verena Schwachmeyer; Markus O Heller; Tilman Pfitzner; Georg N Duda Journal: J Neuroeng Rehabil Date: 2018-11-08 Impact factor: 4.262